- About
-
Projects
-
Column 1
- Advancing Regulatory Science
- Animal Health & Veterinary Medicine
- Expanded Access
- FDA Patient Listening Sessions
-
Column 2
- Food & Nutrition
- Improving Access to FDA Information
- Research
- Substance Use Disorders
-
Column 1
- News and Events
- Expanded Access eRequest
Announcements
Maintaining America's Leadership in Biomedical Innovation: FDA's Role in Advancing U.S. Drug Development Written Testimony
The Reagan-Udall Foundation for the FDA invites nominations for its annual Innovations in Regulatory Science & Policy Awards.
Coverage
Developed with the Alliance for Longevity Initiatives / Healthspan Action Coalition. Fleming presented it at the Reagan-Udall Foundation in May 2026.
But Justice says the organization is engaging with the broader debate over how gerotherapeutics might eventually navigate regulatory pathways – including through recent discussions at the Reagan-Udall Foundation.
Hosted by the Reagan-Udall Foundation for the FDA, the meeting brings together representatives from federal agencies, clinicians, researchers, and patient organizations to discuss approaches for identifying promising drug repurposing candidates for…